Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L.

被引：32

作者：

Findlay, VL

Zilberg, D

Munday, BL

机构：

[1] Univ Tasmania, Sch Biomed Sci, Launceston, Tas 7250, Australia

[2] Univ Tasmania, Sch Aquaculture, Launceston, Tas 7250, Australia

[3] Cooperat Res Ctr Aquaculture, Sydney, NSW, Australia

[4] Australian Quarantine Inspect Serv, Canberra, ACT 2601, Australia

来源：

JOURNAL OF FISH DISEASES | 2000年 / 23卷 / 03期

关键词：

D O I：

10.1046/j.1365-2761.2000.00238.x

中图分类号：

S9 [水产、渔业];

学科分类号：

0908 ;

摘要：

Levamisole, a known T-cell stimulator and immunomodulator in mammals, has been demonstrated to enhance resistance to amoebic gill disease in Atlantic salmon, Salmo salar L. When used in fresh water baths, dose rates of 1.25, 2.5 and 5 ppm levamisole stimulated resistance to reinfection with Paramoeba sp, that was evident from 2-3 weeks post-treatment. It is proposed that this response is related to enhancement of the non-specific immune system.

引用

页码：193 / 198

页数：6

共 24 条

[1] Immunological aspects of amoebic gill disease in salmonids [J].